Variations and increase in use of statins across Europe: data from administrative databases
BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7461.323-a (Published 05 August 2004) Cite this as: BMJ 2004;329:323
The authors of this paper, Tom Walley and colleagues, have alerted us to some errors in the data in their table (BMJ 2004;328: 385-6). For Ireland, the total use of cerivastatin is in fact 0.416 (not 4.16) million defined daily doses (DDDs); this change affects the overall use of statins in Ireland, which becomes 11.06 (not 14.80) million DDDs a year. The value for DDDs per 1000 head of population in Italy is correct as stated. For France, the total use of atorvastatin is 236.58 (not 357.52) million DDDs, and the value for DDDs per head of population is 15.58 (not 23.56); these changes affect France's overall use of statins and its overall rate of use—these values become 730.46 (not 846.88) million DDDs and 48.11 (55.82) DDDs per head of population respectively.